Aspirin for primary prevention of cardiovascular disease?

Area of Science:

• Cardiology
• Preventive Medicine
• Pharmacology

Background:

• Cardiovascular disease (CVD) represents a significant global health burden, causing millions of deaths annually.
• Aspirin is widely used for secondary prevention of vascular events.
• Uncertainty exists regarding aspirin's role in primary CVD prevention.

Purpose of the Study:

• To evaluate the role of low-dose aspirin in the primary prevention of cardiovascular events.
• To weigh the potential benefits of aspirin against its associated risks in individuals without prior CVD.

Main Methods:

• Review of existing literature on low-dose aspirin for primary cardiovascular prevention.
• Analysis of the risk-benefit profile of long-term aspirin therapy.

Main Results:

• The benefits of aspirin for primary CVD prevention are debated.
• Long-term low-dose aspirin therapy significantly increases the risk of gastrointestinal hemorrhage.

Conclusions:

• The use of low-dose aspirin for primary prevention of cardiovascular disease requires careful consideration of individual risk factors.
• Further research is needed to clarify the net benefit of aspirin in specific populations for primary prevention.